Metagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improves the Survival of Patients with Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation

Abstract Introduction Unbiased metagenomic next-generation sequencing (mNGS) has been used for infection diagnosis. In this study, we explored the clinical diagnosis value of mNGS for pulmonary complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods From August 20...

Full description

Bibliographic Details
Main Authors: Zaihong Shen, Ying Wang, Aihua Bao, Jun Yang, Xi Sun, Yu Cai, Liping Wan, Chongmei Huang, Xiaowei Xu, Jiahua Niu, Xinxin Xia, Chang Shen, Yu Wei, Huiying Qiu, Kun Zhou, Min Zhang, Yin Tong, Xianmin Song
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-08-01
Series:Infectious Diseases and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40121-023-00850-w
_version_ 1797682619936145408
author Zaihong Shen
Ying Wang
Aihua Bao
Jun Yang
Xi Sun
Yu Cai
Liping Wan
Chongmei Huang
Xiaowei Xu
Jiahua Niu
Xinxin Xia
Chang Shen
Yu Wei
Huiying Qiu
Kun Zhou
Min Zhang
Yin Tong
Xianmin Song
author_facet Zaihong Shen
Ying Wang
Aihua Bao
Jun Yang
Xi Sun
Yu Cai
Liping Wan
Chongmei Huang
Xiaowei Xu
Jiahua Niu
Xinxin Xia
Chang Shen
Yu Wei
Huiying Qiu
Kun Zhou
Min Zhang
Yin Tong
Xianmin Song
author_sort Zaihong Shen
collection DOAJ
description Abstract Introduction Unbiased metagenomic next-generation sequencing (mNGS) has been used for infection diagnosis. In this study, we explored the clinical diagnosis value of mNGS for pulmonary complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods From August 2019 to June 2021, a prospective study was performed to comparatively analyze the pathogenic results of mNGS and conventional tests for bronchoalveolar lavage fluid (BALF) from 134 cases involving 101 patients with pulmonary complications after allo-HSCT. Results More pathogens were identified by mNGS than with conventional tests (226 vs 120). For bacteria, the diagnostic sensitivity (P = 0.144) and specificity (P = 0.687) were similar between the two methods. For fungus except Pneumocystis jirovecii (PJ), conventional tests had a significantly higher sensitivity (P = 0.013) with a similarly high specificity (P = 0.109). The sensitivities for bacteria and fungi could be increased with the combination of the two methods. As for PJ, both the sensitivity (100%) and specificity (99.12%) of mNGS were very high. For viruses, the sensitivity of mNGS was significantly higher (P = 0.021) and the negative predictive value (NPV) was 95.74% (84.27–99.26%). Pulmonary infection complications accounted for 90.30% and bacterium was the most common pathogen whether in single infection (63.43%) or mixed infection (81.08%). The 6-month overall survival (OS) of 88.89% in the early group (mNGS ≤ 7 days) was significantly higher than that of 65.52% (HR 0.287, 95% CI 0.101–0.819, P = 0.006) in the late group (mNGS > 7 days). Conclusions mNGS for BALF could facilitate accurate and fast diagnosis for pulmonary complications. Early mNGS could improve the prognosis of patients with pulmonary complications after allo-HSCT. Trial Registration ClinicalTrials.gov identifier, NCT 04051372.
first_indexed 2024-03-12T00:02:26Z
format Article
id doaj.art-b2a853b350a3456698a438f2d7b39166
institution Directory Open Access Journal
issn 2193-8229
2193-6382
language English
last_indexed 2024-03-12T00:02:26Z
publishDate 2023-08-01
publisher Adis, Springer Healthcare
record_format Article
series Infectious Diseases and Therapy
spelling doaj.art-b2a853b350a3456698a438f2d7b391662023-09-17T11:22:22ZengAdis, Springer HealthcareInfectious Diseases and Therapy2193-82292193-63822023-08-011282103211510.1007/s40121-023-00850-wMetagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improves the Survival of Patients with Pulmonary Complications After Allogeneic Hematopoietic Stem Cell TransplantationZaihong Shen0Ying Wang1Aihua Bao2Jun Yang3Xi Sun4Yu Cai5Liping Wan6Chongmei Huang7Xiaowei Xu8Jiahua Niu9Xinxin Xia10Chang Shen11Yu Wei12Huiying Qiu13Kun Zhou14Min Zhang15Yin Tong16Xianmin Song17Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineAbstract Introduction Unbiased metagenomic next-generation sequencing (mNGS) has been used for infection diagnosis. In this study, we explored the clinical diagnosis value of mNGS for pulmonary complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods From August 2019 to June 2021, a prospective study was performed to comparatively analyze the pathogenic results of mNGS and conventional tests for bronchoalveolar lavage fluid (BALF) from 134 cases involving 101 patients with pulmonary complications after allo-HSCT. Results More pathogens were identified by mNGS than with conventional tests (226 vs 120). For bacteria, the diagnostic sensitivity (P = 0.144) and specificity (P = 0.687) were similar between the two methods. For fungus except Pneumocystis jirovecii (PJ), conventional tests had a significantly higher sensitivity (P = 0.013) with a similarly high specificity (P = 0.109). The sensitivities for bacteria and fungi could be increased with the combination of the two methods. As for PJ, both the sensitivity (100%) and specificity (99.12%) of mNGS were very high. For viruses, the sensitivity of mNGS was significantly higher (P = 0.021) and the negative predictive value (NPV) was 95.74% (84.27–99.26%). Pulmonary infection complications accounted for 90.30% and bacterium was the most common pathogen whether in single infection (63.43%) or mixed infection (81.08%). The 6-month overall survival (OS) of 88.89% in the early group (mNGS ≤ 7 days) was significantly higher than that of 65.52% (HR 0.287, 95% CI 0.101–0.819, P = 0.006) in the late group (mNGS > 7 days). Conclusions mNGS for BALF could facilitate accurate and fast diagnosis for pulmonary complications. Early mNGS could improve the prognosis of patients with pulmonary complications after allo-HSCT. Trial Registration ClinicalTrials.gov identifier, NCT 04051372.https://doi.org/10.1007/s40121-023-00850-wMetagenomic next-generation sequencing (mNGS)Pulmonary complicationAllogeneic hematopoietic stem cell transplantationBronchoalveolar lavage fluid
spellingShingle Zaihong Shen
Ying Wang
Aihua Bao
Jun Yang
Xi Sun
Yu Cai
Liping Wan
Chongmei Huang
Xiaowei Xu
Jiahua Niu
Xinxin Xia
Chang Shen
Yu Wei
Huiying Qiu
Kun Zhou
Min Zhang
Yin Tong
Xianmin Song
Metagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improves the Survival of Patients with Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Infectious Diseases and Therapy
Metagenomic next-generation sequencing (mNGS)
Pulmonary complication
Allogeneic hematopoietic stem cell transplantation
Bronchoalveolar lavage fluid
title Metagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improves the Survival of Patients with Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation
title_full Metagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improves the Survival of Patients with Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation
title_fullStr Metagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improves the Survival of Patients with Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation
title_full_unstemmed Metagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improves the Survival of Patients with Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation
title_short Metagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improves the Survival of Patients with Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation
title_sort metagenomic next generation sequencing for pathogens in bronchoalveolar lavage fluid improves the survival of patients with pulmonary complications after allogeneic hematopoietic stem cell transplantation
topic Metagenomic next-generation sequencing (mNGS)
Pulmonary complication
Allogeneic hematopoietic stem cell transplantation
Bronchoalveolar lavage fluid
url https://doi.org/10.1007/s40121-023-00850-w
work_keys_str_mv AT zaihongshen metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT yingwang metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT aihuabao metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT junyang metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT xisun metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT yucai metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT lipingwan metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT chongmeihuang metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT xiaoweixu metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT jiahuaniu metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT xinxinxia metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT changshen metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT yuwei metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT huiyingqiu metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT kunzhou metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT minzhang metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT yintong metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation
AT xianminsong metagenomicnextgenerationsequencingforpathogensinbronchoalveolarlavagefluidimprovesthesurvivalofpatientswithpulmonarycomplicationsafterallogeneichematopoieticstemcelltransplantation